Page last updated: 2024-10-24

carmustine and Kidney Neoplasms

carmustine has been researched along with Kidney Neoplasms in 6 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Kidney Neoplasms: Tumors or cancers of the KIDNEY.

Research Excerpts

ExcerptRelevanceReference
" Two patients had severe adverse events thought to be related to wafer placement, one with seizures alone, and one with seizures and subsequent respiratory compromise."2.73Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control. ( Brem, S; Carey, LA; Cush, S; Ewend, MG; Gilbert, M; Goodkin, R; Penar, PL; Varia, M, 2007)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mertins, SD1
Myers, TG1
Holbeck, SL1
Medina-Perez, W1
Wang, E1
Kohlhagen, G1
Pommier, Y1
Bates, SE1
Ewend, MG1
Brem, S1
Gilbert, M1
Goodkin, R1
Penar, PL1
Varia, M1
Cush, S1
Carey, LA1
Stein, BS1
Kendall, AR1
Sufrin, G1
Murphy, GP1
Slavik, M1
Pine, MJ1
Huben, RP1
Pegg, AE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Urinary Excretion of Acetylamantadine by Cancer Patients[NCT02277938]120 participants (Anticipated)Observational2013-08-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for carmustine and Kidney Neoplasms

ArticleYear
Malignant melanoma of the genitourinary tract.
    The Journal of urology, 1984, Volume: 132, Issue:5

    Topics: Adrenal Gland Neoplasms; Adult; Aged; BCG Vaccine; Carmustine; Combined Modality Therapy; Dacarbazin

1984

Trials

1 trial available for carmustine and Kidney Neoplasms

ArticleYear
Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Jun-15, Volume: 13, Issue:12

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Carmustine; Combi

2007

Other Studies

4 other studies available for carmustine and Kidney Neoplasms

ArticleYear
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:7

    Topics: Alkylating Agents; Animals; Bromodeoxyuridine; Busulfan; Carcinoma, Renal Cell; Carmustine; Cell Cyc

2004
Pharmacokinetic studies of a transplantable murine renal adenocarcinoma.
    Investigative urology, 1977, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Animals; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Eval

1977
Clinical studies with nitrosoureas in various solid tumors.
    Cancer treatment reports, 1976, Volume: 60, Issue:6

    Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Carmustine; Female; Genital Neoplasms, F

1976
Production of N1-acetyl spermidine by renal cell tumors.
    The Journal of urology, 1989, Volume: 141, Issue:3

    Topics: Animals; Carcinoma, Renal Cell; Carmustine; Eflornithine; Female; Kidney Neoplasms; Mice; Mice, Inbr

1989